Feed aggregator

1E Therapeutics Raises $120 Million in Seed Funding

Biospace news - Thu, 12/09/2021 - 02:00
1E Therapeutics announced $120 million seed funding, a remarkable feat for an early-stage biotech company. The funding is the largest of its kind for an Israeli biotech company.

What Should You Post About on LinkedIn?

Biospace news - Thu, 12/09/2021 - 02:00
Instead of letting LinkedIn slide to the bottom of your to-do list day after day, block off an hour on your calendar once a week to create a post and engage with your connections.

Signs That You Should or Shouldn’t Switch Your Job

Biospace news - Thu, 12/09/2021 - 02:00
Deciding on when to switch your job can be a difficult decision to make.

Cancer Diagnostics Company CEO is Stephen Hahn's Next Act

Biospace news - Wed, 12/08/2021 - 02:00
At Harbinger, Hahn will oversee the development of the Bio-AI diagnostics platform dubbed HarbingerHx, in hopes of detecting cancer in a patient before it is visible or symptomatic.

Newpath Commits $350 Million to Fund the Next Good Things in the Life Sciences

Biospace news - Wed, 12/08/2021 - 02:00
Newpath is guided by the ethos: “Do the right thing and good things will happen."

Report: Biogen Eyes Massive Layoffs in Wake of Disappointing Aduhelm Rollout

Biospace news - Wed, 12/08/2021 - 02:00
The company could lay off as many as 1,000 employees as it continues to deal with the controversial treatment.

Avistone Scores $200 Million to Target Molecular Drivers of Cancer

Biospace news - Wed, 12/08/2021 - 02:00
On Wednesday, clinical-stage biotech Avistone Pharmaceuticals announced that it has raised more than $200 million of financial backing to support its business combination with Pearl Biotechnology.

Life Sciences Expansions Take Off as 2021 Wraps Up

Biospace news - Wed, 12/08/2021 - 02:00
Several life sciences companies and life science-focused real estate firms have announced expansion plans as 2021 comes to an end.

Alleged Sabatini Sexual Harassment Victim Files Countersuit

Biospace news - Wed, 12/08/2021 - 02:00
The counterclaim by an alleged victim of MIT professor David Sabatini said she was coerced into sex and that Sabatini's laboratory had a “toxic and sexually charged” environment.

Study Calls Out Lack of Reproducibility in Cancer Research

Biospace news - Wed, 12/08/2021 - 02:00
​Known as the Reproducibility Project: Cancer Biology, it spent eight years replicating experiments from high-impact cancer biology papers published between 2010 and 2012.

LAG-3 Pioneer Frédéric Triebel Discusses Its Potential in Immunotherapy

Biospace news - Wed, 12/08/2021 - 02:00
LAG-3 is a priority focus in cancer immunotherapy because its inhibition has the potential to make PD-1 inhibitors work in more patients.

With Positive Data in Hand, Neurocrine and Acadia Prepare for NDAs

Biospace news - Wed, 12/08/2021 - 02:00
​Neurocrine Biosciences and Acadia Pharmaceuticals posted positive top-line results from their respective Phase III trials on major neurological diseases.

Pfizer Reassures with Booster Data After Reports of Lowered Omicron Protection

Biospace news - Wed, 12/08/2021 - 02:00
Pfizer's preliminary laboratory studies have shown that the third booster dose increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant.

Former Martin Shkreli Company Vyera Settles Federal Lawsuit for $40 Million

Biospace news - Wed, 12/08/2021 - 02:00
Vyera Pharmaceuticals agreed to pay $40 million to settle federal allegations to radically increase the price of toxoplasmosis drug Daraprim and prevent generic competition.

Alvotech Unites with Oaktree in $2.25 Billion Merger to Advance Biosimilars

Biospace news - Tue, 12/07/2021 - 02:00
​Biopharmaceutical firm Alvotech Holdings announced merger plans with Oaktree Acquisition Corp. in a deal that will create a combined entity worth around $2.25 billion.

Merck Pauses Two More HIV Trials in Light of Recent Findings

Biospace news - Tue, 12/07/2021 - 02:00
The news comes just three weeks after Merck paused its Phase II IMAGINE-DR trial, which was studying a combination of islatravir with MK-8507.

Odyssey to Aim $218 Million at Novel Targets

Biospace news - Tue, 12/07/2021 - 02:00
Odyssey Therapeutics completed an oversubscribed $218 million Series A round. The funds will be used to advance multiple programs from its pipeline and its discovery platform.

Recursion and Roche Ink Multi-Billion Dollar AI Deal

Biospace news - Tue, 12/07/2021 - 02:00
Recursion entered into a billion-dollar “transformational collaboration” with Roche to identify and develop up to 40 new medications for neuroscience and oncology.

What Omicron Could Teach Us About Predicting Future COVID-19 Variants

Biospace news - Tue, 12/07/2021 - 02:00
Despite having 37 new mutations in the viral spike protein, there does not appear to be any deaths associated with Omicron, although it’s spreading rapidly in South Africa.

METiS Launches to Take Drug Development a Quantum Leap Ahead

Biospace news - Tue, 12/07/2021 - 02:00
The Cambridge, Massachusetts-based company has developed an artificial intelligence platform designed to optimize pharmaceutical formulation processes.